PFAS and Environmental Class Actions in Canada
PFAS class actions are moving from the United States to Canada. With federal findings that the PFAS class meets CEPA's toxicity criteria and phased prohibitions under way, manufacturers, site operators and insurers should understand the theories plaintiffs plead, the certification hurdles and the steps that strengthen a defence.

Key takeaways
- Health Canada's March 2025 State of PFAS Report found the class, excluding fluoropolymers, meets CEPA section 64 criteria.
- A proposed order to add PFAS to Schedule 1 was published on 8 March 2025; no final order was listed.
- Claims combine product liability, nuisance, negligence, consumer protection and public-body cost recovery.
- Ontario's predominance and superiority tests give defendants real arguments at certification.
- Historical CGL policies and early insurance archaeology can be decisive.
- Document preservation, site mapping and contractual indemnity reviews should start before a claim.
What PFAS class actions are and why they are coming to Canada
PFAS class actions are collective lawsuits alleging that per- and polyfluoroalkyl substances (the so-called "forever chemicals") contaminated water, land, products or people, and that manufacturers, distributors or users should pay for testing, remediation, medical monitoring or loss of property value. In the United States, aqueous film-forming foam (AFFF) and drinking-water litigation has produced some of the largest environmental settlements on record. Canada has not yet seen comparable verdicts, but the legal building blocks are in place: a federal finding that the class of PFAS meets the toxicity criteria under the Canadian Environmental Protection Act, 1999 (CEPA), provincial class proceedings statutes designed for mass claims, and a plaintiffs' bar experienced in product and environmental cases.

For manufacturers, importers, airports, fire services, landfill operators, textile and packaging businesses and the insurers behind them, the question is no longer whether such claims can be framed in Canada, but how early decisions on records, testing and coverage will shape exposure. This insight explains the theories plaintiffs use, the regulatory record they rely on, the certification hurdles defendants can press, and the practical steps worth taking now. It is general information, not legal advice on any particular situation.
The federal regulatory record plaintiffs will rely on
Canada has regulated individual PFAS for years. PFOS, PFOA and long-chain perfluorocarboxylic acids were addressed through CEPA prohibition regulations, and Health Canada maintains pages on each subgroup. The broader shift came with the class-based approach. According to Health Canada's PFAS page (last modified 26 September 2025), the government published the State of Per- and Polyfluoroalkyl Substances (PFAS) Report in March 2025, concluding that the class of PFAS, excluding fluoropolymers, meets one or more of the criteria in section 64 of CEPA. A proposed order adding that class to Part 2 of Schedule 1 to CEPA was published in the Canada Gazette, Part I, on 8 March 2025 with a 60-day comment period. As of the page we reviewed, no final order was listed.
The government has also proposed a phased prohibition. Phase 1 targets PFAS not already regulated in firefighting foams, with a consultation document published on 26 September 2025. Later phases are expected to address other uses. For litigation purposes, these documents matter in three ways: they supply an official hazard narrative, they show what was knowable and when, and they set a regulatory baseline that plaintiffs will argue defines the standard of care.
| Regulatory milestone | Date (per Health Canada) | Likely use in PFAS class actions |
|---|---|---|
| Final State of PFAS Report | March 2025 | Evidence of hazard and of the state of knowledge |
| Proposed order adding PFAS (excluding fluoropolymers) to Schedule 1 | 8 March 2025 (Canada Gazette, Part I) | Argued as official recognition of toxicity; defendants stress it is a risk-management tool, not proof of causation |
| Phase 1 consultation on firefighting foams | 26 September 2025 | Relevant to AFFF users such as airports, military sites and fire training areas |
| Earlier prohibitions on PFOS, PFOA and long-chain PFCAs | Various | Used to argue that risks of specific substances were known for years |
Defendants should resist the jump from a CEPA designation to liability. A Schedule 1 listing reflects a precautionary, population-level assessment under section 64; it does not establish that a particular product caused a particular plaintiff's illness or a specific property's loss. That distinction becomes central at certification and trial.
Liability theories in PFAS class actions
Canadian PFAS class actions are likely to combine several causes of action. Each carries different proof requirements, and the mix affects whether a court will find common issues.
Product-based claims
Consumer claims target goods containing PFAS, such as stain-resistant textiles, cosmetics, food packaging or cookware. Plaintiffs typically plead negligent design, failure to warn, breach of provincial consumer protection statutes and, sometimes, misrepresentation where products were marketed as "safe" or "non-toxic". In Quebec, the manufacturer's liability for safety defects under the Civil Code of Québec and the Consumer Protection Act make such claims easier to frame. Marketing claims also intersect with the Competition Act's deceptive-marketing provisions; see our page on deceptive marketing and greenwashing.
Site-contamination claims
Site claims arise where PFAS migrated from airports, industrial plants, landfills, wastewater biosolids or fire training areas into groundwater and neighbouring land. Typical causes of action are nuisance, negligence, trespass, the rule in Rylands v. Fletcher and statutory causes of action under provincial environmental statutes. Claimants seek remediation costs, diminution in property value, alternative water supply and, in some cases, medical monitoring. Property-value claims are attractive to plaintiffs because they can sometimes be proven on an aggregate basis.
Public-body and municipal claims
In the US, water utilities and states drove the AFFF litigation. Canadian municipalities and provinces could pursue cost recovery for treatment upgrades. Provincial legislation that allows a government to sue on behalf of others has been upheld in another mass-tort context: in Sanis Health Inc. v. British Columbia, 2024 SCC 40, the Supreme Court of Canada confirmed the constitutionality of BC's opioid statute permitting a class action on behalf of other governments. That model could be replicated for environmental contaminants.
Certification hurdles for PFAS class actions
Certification is where most Canadian class actions are won or lost on scope. In Ontario, the Class Proceedings Act, 1992 (CPA) was amended in 2020 so that a class proceeding must be the preferable procedure and, in particular, common issues must predominate over individual issues and the class action must be superior to other reasonably available means (s. 5(1.1)). In Quebec, authorization under art. 575 of the Code of Civil Procedure remains a lower screening threshold. Other common-law provinces follow their own statutes, generally without the Ontario predominance and superiority requirements.
Defendants in PFAS class actions have strong arguments on several points:
- General and specific causation. There are thousands of PFAS with different toxicological profiles. A claim pleaded against "PFAS" as a class may not raise a common issue on whether a particular compound causes a particular disease.
- Exposure pathways. Background exposure from diet, consumer products and air means individual exposure histories vary widely, which undermines commonality and predominance.
- Multiple sources. Where several facilities or products could have contributed to a plume, apportionment raises individual issues.
- Medical monitoring. Canadian courts have been cautious about stand-alone medical monitoring claims absent present injury; plaintiffs will need expert evidence of a real increased risk.
- Class definition. Classes defined by proximity to a site must rest on evidence of a plume, not just geography.
Many PFAS defences are won or lost on documents created long before any claim: historical purchasing records for foams and coatings, safety data sheets, sampling results and internal emails. Put a litigation hold in place as soon as a claim is reasonably anticipated, and route sampling and expert retainers through counsel where privilege is available.
Insurance coverage for PFAS claims
PFAS claims will test commercial general liability (CGL) wordings that were written decades ago. Key questions include whether the claim alleges "property damage" or "bodily injury" during the policy period, the reach of pollution exclusions, the trigger of coverage for long-tail contamination, and allocation across many policy years and insurers. In Canada, the duty to defend is triggered by the mere possibility that the pleaded claim falls within coverage, following Progressive Homes Ltd. v. Lombard General Insurance Co. of Canada, 2010 SCC 33. Insurers increasingly add specific PFAS exclusions to new policies, so historical occurrence-based policies may be the most valuable assets an organization has.
Insurance archaeology (locating old policies, broker records and certificates) should begin early. For more on how Canadian courts read policy language, see our insight on insurance coverage disputes.
Defence strategies for manufacturers and users
A sound defence plan for PFAS class actions starts before a claim is served. The following steps are commonly useful:
- Map PFAS in your operations. Identify which products, process aids and site activities used PFAS, which compounds, and when. This informs regulatory compliance under the forthcoming CEPA measures and frames litigation risk.
- Assess legacy sites. For owned or previously owned property, review environmental reports for PFAS sampling. Provincial regulators are adding PFAS to site-condition standards, and transaction diligence increasingly asks for it.
- Review contractual protections. Supply agreements, asset purchase agreements and leases may contain environmental indemnities that shift or share PFAS liability. Notice provisions often have strict deadlines.
- Prepare scientific evidence. Retain toxicology, hydrogeology and epidemiology experts early. At certification, expert evidence on why issues are not common can narrow or defeat a class.
- Coordinate across jurisdictions. Overlapping proposed classes in Ontario, Quebec and British Columbia are common. Consistent positions and early carriage motions avoid duplicated costs; see our insight on multi-jurisdictional class actions.
- Watch limitation periods. Ontario's Limitations Act, 2002 sets a two-year discoverability period and a 15-year ultimate period. Discoverability arguments in contamination cases are fact-intensive and can cut both ways.
Settlement is often the rational endpoint of mass environmental litigation. If PFAS class actions settle, court approval in each province will require a fair and reasonable settlement in the best interests of the class, with full disclosure of risks and the distribution plan. Our insight on class action settlement approval explains the process.
PFAS class actions and transactions
The risk of PFAS class actions now appears in M&A and financing due diligence. Buyers ask about PFAS use, sampling and complaints; lenders request environmental reports that test for PFAS; and representations and warranties insurers may exclude known PFAS exposures. Sellers can reduce friction by preparing a PFAS disclosure package and, where needed, negotiating specific indemnities or escrow mechanisms. Environmental regulatory obligations interact with this risk; our environmental and climate law page outlines the wider framework.
Pricing PFAS risk in a deal is difficult because the science and the regulation are both moving. Practical tools include special indemnities that survive longer than general representations, holdbacks tied to sampling results, covenants requiring the seller to complete defined investigations before closing, and purchase-price adjustments for known remediation. Where the target is a supplier of PFAS-containing components, buyers should also look at customer contracts: downstream customers facing PFAS class actions may seek contribution or indemnity from their suppliers, and those claims can arrive years after closing.
Corporate boards should treat PFAS like other emerging-contaminant risks: identify the exposure, assign management ownership, report periodically and consider disclosure obligations for reporting issuers where the risk is material.
How TRW & Co helps
We advise manufacturers, distributors, industrial operators and investors on Canadian law relating to PFAS class actions and environmental liability. Our work includes mapping PFAS exposure across products and sites, reviewing supply-chain and transaction indemnities, organizing insurance archaeology and coverage notices, and preparing certification defence strategies with scientific experts. Where court proceedings require counsel licensed in a particular province, we work alongside locally licensed litigation counsel and coordinate positions across Ontario, Quebec and British Columbia. We also help boards and in-house teams set up litigation holds, privilege protocols and disclosure assessments before claims crystallize. To discuss a specific situation, contact us.
Frequently asked questions
Have PFAS class actions been certified in Canada?
Proposed PFAS-related class actions have been filed, but Canada has not produced anything comparable to the large US settlements. Certification outcomes will depend on how narrowly classes and compounds are defined, the expert evidence on causation, and, in Ontario, whether common issues predominate and a class action is superior to other means. Each case should be assessed on its own pleadings and evidence.
Does adding PFAS to CEPA Schedule 1 prove liability?
No. A Schedule 1 listing reflects a finding that a substance meets one or more criteria in section 64 of CEPA, which supports risk-management regulation. It does not establish that a given product or site caused a specific injury or loss. Plaintiffs will use it as context, while defendants will emphasize the gap between precautionary regulation and proof of causation.
Who is most exposed to PFAS litigation in Canada?
Exposure is highest for manufacturers and importers of PFAS chemicals or treated products, users of firefighting foams such as airports and industrial sites, landfill and wastewater operators, and owners of contaminated land. Insurers, lenders and buyers of those businesses also carry indirect exposure through coverage, security and indemnities.
Will insurance cover PFAS claims?
It depends on the policy wording and period. Older occurrence-based CGL policies may respond, subject to pollution exclusions and trigger and allocation issues. Newer policies often contain specific PFAS exclusions. Because the duty to defend is triggered by a possibility of coverage, giving prompt notice to all potentially responsive insurers is important.
What should a company do first?
Identify where PFAS were used or released, preserve relevant records, review insurance and contractual indemnities, and obtain privileged expert advice on sites with known contamination. These steps support both regulatory compliance and a credible defence if claims arrive.
Sources
General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.


